ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Endeavor Biomedicines, Inc. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
next-generation-sequencingngs
solid tumors with ptch1 loss-of-function mutations, patched-1, ptch1, hedgehog inhibitor, smoothened inhibitor, endeavor, ngs, next generation sequencing, head and neck, laryngeal, hypopharyngeal, nasal cavity
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 840164
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.